Polycystic ovary syndrome and hyperprolactinemia

Obstetrics and Gynecology Clinics of North America

Volumn 28, Issue 1, 2001, Pages 77-84

  Bracero, N ^a   Zacur, H A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; CLOMIFENE CITRATE;

ANOVULATION; HUMAN; HYPERANDROGENISM; HYPERPROLACTINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; OVARY CYCLE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PROLACTIN RELEASE; REVIEW; WEIGHT REDUCTION;

EID: 0035079780     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(05)70186-8     Document Type: Article

References (55)

1. Prevalence of oligomenorrhea in college population
2. Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation
3. Effects of dopamine and metoclopramide in polycystic ovary syndrome
4. Adrenal androgen production in hyperprolactinemic states
5. The comparative endocrinology of prolactin
6. Hyperprolactinemic anovulatory syndrome
7. A double blind controlled study of the hormonal and clinical effects of bromocriptine in the polycystic ovary syndrome
8. Adrenocortical function in hyperprolactinemic women
9. Cellular mechanisms of insulin resistance in policystic ovarian syndrome
10. Effect of androgens on prolactin (PRL) release in humans
11. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
12. The epidemiology of secondary amenorrhea
13. Theca function in polycystic ovaries of a patient with virilizing congenital adrenal hyperplesia
14. Molecular biology of prolactin: Cell-specific and endocrine regulators of the prolactin gene
15. Syndrome characterized by galactorrhea, amenorrhea and low urinary FSH. Comparison with acromegaly and normal lactation
16. Incidence and significance of hyperprolactinemia in women with amenorrhea
17. Policystic ovary syndrome
18. Lack of correlation of ultrasonographically determined ovarian size with age, ponderal index, and hormonal factors in 45 patients with polycystic ovarian disease
19. Factors involved in the control of the activity of the tubero infundibular neurons during pregnancy and lactation
20. Growth of a microprolactinoma during estrogen therapy
21. Epidemiology of infertility and policystic ovarian disease: Endocrinological and demographic studies
22. Purification of human prolactin
23. Therapy oriented diagnosis of secondary amenorrhea
24. Inhibition of gonadotropins and prolactin release of dopamine. Effect of endogenous estrogen levels
25. Androgen and cortisol response to ACTH stimulation in women with hyperprolactimenia
26. In vitro production by a virilizing adrenal adenoma and associated polycystic ovaries
27. Galactorrhea and amenorrhea with polycystic ovaries
28. The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system
29. The structure and function of dopamine receptors
30. Prolactin release in polycystic ovarian syndrome
31. Studies of prolactin secretion in polycystic ovary syndrome
32. Physiological actions of prolactin
33. Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome
34. Induced prolactin release in women under long-term medroxyprogesterone acetate treatment
35. Epidemiology of secondary amenorrhea. Incidence and prevalence rates
36. Opioid, catecholamine and steroid interaction in prolactin and gonadotropins regulation
37. Characterization of the inappropriate gonadotropins secretion in polycystic ovary syndrome
38. Adult onset amenorrhea: A study of 262 patients
39. Raised serum prolactin levels associated with hirsutism and amenorrhea
40. Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome
41. Menstrual disorders in college students
42. Pathogenesis of polycystic ovaries
43. Anovulation and the polycystic ovary
44. Amenorrhea associated with bilateral polycystics ovaries
45. The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease
46. Effects of ovarian surgery on the dopaminergic and opioidergic control of gonadotropin and prolactin secretion in women with polycystic ovarian disease
47. Pigeon crop weight responses to the application of extracts from the blood of women with Stein-Leventhal syndrome, galactorrhea and of those in the secretory phase of the menstrual cycle (including critical remarks of the method by Simkin and Goodard)
48. Variation of the human menstrual cycle through reproductive life
49. Hyperprolactinemia and polycystic ovarian syndrome
50. Radiographic abnormalities in patients with Stein-Levanthal syndrome
51. Small cystic degeneration of ovaries as incidental finding in gynecological laparatomies
52. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease
53. Multifactional regulation of prolactin
54. Autoregulation of rat pituitary prolactin secretion demonstrated by a new perfusion method
55. Plasma dopamine-beta-hydroxylase activity and norepinephrine levels during the human menstrual cycle